Looking to read the full article? Subscribe to BioWorld MedTech.

Butterfly Medical takes flight with $7M series B financing and positive feasibility data

October 20, 2020

Butterfly Medical Ltd. could be on the verge of metamorphosis into a major player in the benign prostatic hyperplasia treatment field. The Yokneam, Israel-based company just raised $7 million in a series B financing led by New Rhein Healthcare Investors LLC, of Philadelphia.

BioWorld MedTech Financings Urology Series B Middle East North Africa

Already a subscriber? Sign in

Today's news in brief

BioWorld

BioWorld briefs for Oct. 29.

Today's news in brief

BioWorld MedTech

BioWorld MedTech's briefs for Oct. 29.

Daily aspirin gains new attention in COVID-19 fight while antiviral drug trial stopped

BioWorld

Interest in testing the mettle of three widely available drugs against COVID-19 gained traction Monday, led by suggestions that daily low-dose aspirin might lower...

Arrowhead cuts a $1B ‘no-brainer’ deal with Takeda

BioWorld

In a deal that could bring the company as much as $1.04 billion, Arrowhead Pharmaceuticals Inc. will collaborate with Takeda Pharmaceutical Co. Ltd. to co-develop...

Kathryn Atkinson, an elderly patient, participating in a smartphone screening test to analyze stroke-like symptoms

AI-based app can diagnose stroke in minutes

BioWorld MedTech

A new tool for mobile devices can diagnose stroke as accurately as an emergency medicine specialist in just minutes, enabling patients to get brain-saving...